- Home
- ZLAB vs HTH Comparison
ZLAB vs HTH Comparison
Compare ZLAB & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- HTH
- Stock Information
- Founded
- ZLAB 2013
- HTH 1998
- Country
- ZLAB China
- HTH United States
- Employees
- ZLAB N/A
- HTH N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- HTH Major Banks
- Sector
- ZLAB Health Care
- HTH Finance
- Exchange
- ZLAB Nasdaq
- HTH Nasdaq
- Market Cap
- ZLAB 3.6B
- HTH 1.9B
- IPO Year
- ZLAB 2017
- HTH 2004
- Fundamental
- Price
- ZLAB $32.54
- HTH $30.77
- Analyst Decision
- ZLAB Buy
- HTH Hold
- Analyst Count
- ZLAB 5
- HTH 2
- Target Price
- ZLAB $54.28
- HTH $33.00
- AVG Volume (30 Days)
- ZLAB 781.8K
- HTH 468.9K
- Earning Date
- ZLAB 08-05-2025
- HTH 07-24-2025
- Dividend Yield
- ZLAB N/A
- HTH 2.33%
- EPS Growth
- ZLAB N/A
- HTH 15.07
- EPS
- ZLAB N/A
- HTH 1.97
- Revenue
- ZLAB $418,326,000.00
- HTH $1,208,822,000.00
- Revenue This Year
- ZLAB $44.07
- HTH N/A
- Revenue Next Year
- ZLAB $49.13
- HTH $1.36
- P/E Ratio
- ZLAB N/A
- HTH $15.71
- Revenue Growth
- ZLAB 43.72
- HTH 2.13
- 52 Week Low
- ZLAB $16.01
- HTH $26.67
- 52 Week High
- ZLAB $44.34
- HTH $35.32
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- HTH 52.06
- Support Level
- ZLAB $34.26
- HTH $30.92
- Resistance Level
- ZLAB $35.72
- HTH $32.16
- Average True Range (ATR)
- ZLAB 1.12
- HTH 0.53
- MACD
- ZLAB -0.54
- HTH 0.04
- Stochastic Oscillator
- ZLAB 3.83
- HTH 50.34
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.